Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration.

Sohn, Sang Kyun; Kim, Jong Gwang; Kim, Dong Hwan; Lee, Kyu Bo

doi:10.1046/j.1365-2141.2003.04288.x

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration.

Sang Kyun Sohn, Jong Gwang Kim, Dong Hwan Kim, Kyu Bo Lee

Sang Kyun Sohn

NobleIDNI2P56W95R08S17

Type:Journal Article

Claim Your Authorship

Sign in to see the full record

Creating an account is free.

Create an account

For data access, contact info@nobleid.org.

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration | NobleID